CD274 and neoplasm: In this regard, aPD-L1 specifically binds to PD-L1 on the surface of tumor cells to block the PD-1/PD-L1 checkpoint pathway23, which can reinvigorate effector T cells (Teffs) activity and inhibit regulatory T cells (Tregs) function.